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Present study was designed to evaluate the anti-apoptotic activity and anti-inflammatory of phytocompounds of Illicium 
verum fruits. Bioactive compounds from the alcoholic, chloroform and ethylacteate fractions of Illicium verum were selected 
based on GC-MS analysis, which were in silico docked against Caspase 3, Matrix Metalloproteinase 9 and TNF-α. The 
structures of Caspase 3, Matrix Metalloproteinase 9 (MMP-9) and TNF-α enzymes were obtained from the protein data 
bank. Molecular docking was done by using Glide XP module of Schrodinger software and binding energies of ligands were 
also calculated. The phytocompound Strychane,1-acetyl-20α- hydroxy-16-methylene showed good docking score against 
Caspase 3 and TNF-α. The phytocompound Pyrrolidine, 1-(7-oxo-2,4,6 trimethylheptanoyl) showed good docking score 
against MMP-9. The results revealed that phytoconstituents obtained from Illicium verum showed good docking against 
Caspase-3, MMP-9 and TNF-α indicating their potential towards apoptosis and inflammation. 
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Apoptosis or Programmed Cell Death is an energy-
dependent process by which undesirable cells 
undergone self-destruction when the genes of 
apoptosis are activated
1
. The two apoptotic signaling 
cascades are the extrinsic and intrinsic pathways, 
were eminent. The extrinsic pathway is activated by 
engaging of Fas plasma membrane death receptor to 
Fas ligand (Fas-L) and other similar receptors, such as 
TNFR 1. A death complex forms by binding Fas-L 
with Fas. This death complex recruits death domain-
containing protein (FADD) and pro-caspase-8, 
aggregating to become the death-inducing signaling 
complex (DISC)
2
. The protein complex activates pro-
caspase-8, which proceeds to activate pro-caspase-3, 
an eventual enzyme for the execution of apoptotic 
process. Apoptosis also triggers through intrinsic 
pathway but under the control of pro enzymes of 
mitochondria. When a cell is stimulated either 
intracellularly or extracellularly, the mitochondrial 
outer membrane become permeable to cytochrome C, 
which is then liberated into the cytosol. Then 
apoptosome formation takes place when the adaptor 
protein Apaf-1 associates with cytochrome C, which 
triggers caspase 9. Once activated, caspases 8, 9, and 
10 activates caspases 3 and 7, the executioner 
caspases. Caspases 3 and 7 cleaves a pair of 
substrates, resulting in membrane blebbing, nuclear 




MMPs are classified as the matrixins, subfamily of 
zinc metalloprotease family. Matrix metalloproteinases 
also called as matrixins which are zinc-dependent 
endopeptidases and are membrane- bound that have 
the ability to degrade all the components of the 
extracellular matrix. MMP enzymes are tangled in 
normal, pathological, physiological and biological 
processes such as angiogenesis, normal tissue 
remodeling, embryogenesis, wound healing and plays 
a pivotal role in vascular remodeling. Divergent 
action of MMPs has been involved in numerous 
disease conditions. MMPs are considered as central 
participants in management of cell–cell and cell–
ECM communications, and the explanation of their 
potential as medication focuses in illness or as 
significant features of the repair cycle will be needy 
upon cautious examination of their part in various cell 




The inflammatory reaction is an essential body 
protection defense mechanism in response to 
unfavorable inflammogens. This complicated reaction 
entails leukocytes cells which includes neutrophils, 








to as inflammatory cells
5
. In response to the 
inflammatory process, these cells release specialized 
materials which consists of vasoactive amines, 
peptides, proinflammatory cytokines, acute-phase 
proteins, eicosanoids, which mediate inflammation 
with the aid of preventing tissue harm and ultimately 
resulting in recuperation and recovery of tissue 
function
6
. The complete process of the inflammatory 
reaction ismediated through several key regulators 
involved within the selective expression of pro-
inflammatory molecules. The inflammatory passage 
varies depends on the nature of stimulants, so are their 
target tissues. Activation of inflammatory process 
involves in releasing of mediators such as 
inflammatory cytokines like interleukin-1 (IL-1), tumor 
necrosis factor alpha (TNF-α), and interleukin-6 (IL-6) 
and chemokines. The length of inflammatory responses 
relying on the extent of injury caused by the infection. 
The significance of inflammatory conditions in modern 
generation of clinical technological knowhow cannot 
be overvalued due to their involvement in many of 
illnesses inclusive of weight problems, atherosclerosis, 
allergies, neurodegenerative diseases, cancer, 





Illicium verum belongs to the family illiceae. It 
possess antioxidant, antimicrobial, antifungal anti-
inflammatory, anticancer, diuretic, antirheumatic, 
treatment of alzhemier’s disease
8,9,10 
and protection 




The goal of the present study was designed to 
identify bioactive compounds from the alcoholic, 
ethylacetate and chloroform fractions of Illicium 
verum by gas chromatography and mass spectroscopy 
analysis followed by in silico docking analysis to 
validate the activity of the compounds against 
Caspase 3, Matrix metalloproteinase 9 and TNF-α 
enzymes. The compounds were identified based on 
NIST along with retention indices. Schrodinger 
software was used to study molecular docking studies. 
 
Materials and Methods 
 
Collection and identification of plant material 
The fruits of Illicium verum were collected at 
Tirupati, Andhra Pradesh, India. Dried fruits were 
coarsely powdered and were extracted using 
maceration process; briefly first they were soaked in 
ethanol: water (7:3) for 3 days. The macerate filtrate 
was concentrated with rotary evaporator under 
reduced pressure at 40C. The hydroalcoholic extract 
was subjected to partial fractionation successively 
with chloroform and ethylacetate. To this extract  
250 mL of water was added and shaken vigorously 
and 100 mL of ethylacetate was added, the non polar 
constituents were separated. This procedure was 
repeated until the appearance of colorless layer. After 
separation of ethylcetate fraction, 100 mL of 
chloroform was added to the hydroalcoholic extract 
and this procedure was repeated till the chloroform 
layer became colorless. Both the fractions were 
collected and evaporated to get a concentrated 
residue. The remaining portion was considered as 
hydroalcoholic fraction. 
GC MS analysis was performed by JOEL-GC 
MATE II. The equipment has a DB 35-MS capillary 
standard non polar column with dimensions of 30 mm 
× 0.25 mm ID × 0.25 µM. Helium gas was used as a 
carrier at rate of 1 mL/min. Injector was operated at 
250º C and the oven temperature was programmed as 
110C hold for 3.50 min, up to 200C at the rate of 
10C/min-no hold, upto 280C at the rate of 5C 
/min-12 min hold and total running time for GC is  
40 min. The compounds were identified based on 






The software used for this research was Glide tool 
from Schrodinger molecular drug discovery suite. 
 
Docking analysis 
The compounds identified in GC-MS were docked 
to the proteins Caspase 3, MMP9, TNF-α from Homo 
sapiens. The structures of Caspase 3 (PDB Id: 1pau), 
MMP9 (PDB Id: 2ow1) and TNF-α (PDB Id: 2AZ5) 
were obtained from PDB database.  
 
Identification of active site 
 
Preparation of proteins 
The digital structure of Caspase 3, MMP-9, TNF-α 
proteins were retrieved from the Protein databank 
website with PDB Ids: 1pau, 2ow1 and 2AZ5, 
respectively, and the structure was optimized by 
deleting unbound water molecules which were over 1 
Å, hydrogen atoms were added to satisfy the valences, 
side chains were stabilized by adding missing amino 
acids and energy of the whole structure was 
minimized using OPLS-2005 force field using protein 
Preparation Wizard tool of Schrodinger Suite. 




The active site (binding pocket) and functional 
residues of 1pau, 2ow1 and 2AZ5 were identified and 
characterized by site map module from Schrodinger 
software. Site map calculation began with an initial 
search step that identifies or characterized through  
the use of grid points. One or more regions on  
protein surfaces that may be suitable for binding of 
ligands to the receptor. Counter maps were then 
generated, hydrophobic, hydrophilic maps, hydrogen 
binding possibilities guide the protein ligand docking 
analysis. 
 
Molecular docking using glide 
Structurally optimized protein structure was used to 
identify protein-ligand interactions of the ligands 
using Glide Xp docking. Initially, a 3D grid was 
established to the binding pocket (active site) of the 
protein and ligands were docked into the active site of 
protein. Binding efficiency and binding interactions 
were calculated as Glide Score, a combination of 
hydrophobic, hydrophilic, metal binding groups, 
Vander Waals energy, freezing rotatable bonds and 
polar interactions with receptor.  
 
Post docking calculations  
Prime MM/GBSA (molecular mechanics based 
generalized Born/surface area) module of Schrodinger 
suite was used to calculate the binding energies of the 
docked complexes, which is a combination of OPLS 
molecular mechanics energies (EMM), an SGB 
solvation model for polar solvation (GSGB), and a 
non-polar solvation term (GNP) containing non-polar 
solvent accessible surface area and Vander Waals 
interactions. In this, docking results were rescored 
through an energy function with a well-defined 
description of binding contributions. The total free 
energy of binding is then expressed in the form of G 
bind energy as calculated using below mentioned 
equation: 
 
ΔGbind= Gcomplex – (Gprotein + Gligand)  
 
where, ΔGbind is ligand binding energy. 
 
Results and Discussion 
In this study we evaluated the interaction of the 
ligands with one of the markers of inflammation and 
apoptosis proteins. As shown in (Fig. 1A), the 
chromatogram of GC MS analysis revealed the 
presence of six phytocompounds from hydroalcoholic 
fraction, six phytocompounds from ethylacetate 
fraction as shown in (Fig. 1B) and eleven 
phytocompounds from chloroform fraction of Illicium 
verum fruits as shown in (Fig. 1C).The compounds 
were identified based on retention time and classified 
in parallel to NSIT library (Table 1A-C). 
Molecular docking of ligands against the active site 
of the enzymes determines the interactions between 
proteins and ligands. Docking was performed for all 
twenty three compounds. The target proteins selected 
were the biomarkers of apoptosis and inflammation. 
Caspase-3 is the cysteine protease family protein and 
it is a executioner caspase. Caspase-3, a regulatory 
caspase, which controls caspase activated DNAse 
(CAD) activity to complete the process of apoptosis
12
. 
CAD cleaves DNA at internucleosomal linker sites 
between nucleosomes, degradation of nuclear DNA 
into nucleosomal units is one of the hall marks of 
apoptotic cell
13
. Based on the virtual screening score 
of the phytocompounds as tabulated in (Table 2), the 
highest docking score was showed by Strychane,  
1-acetyl-20α- hydroxy-16-methylene with −3.66 score 
for apoptotic marker that is caspase 3 with PDB Id 
1Pauas showed in (Fig. 2). 
Matrix metalloproteinase-9 (MMP9) has been 
involved in many diseases like cardiovascular 
disorders, bipolar illness, schizophrenia, multiple 
sclerosis and cancer
14
. MMP-9 is one of the important 
biomarkers, which could be used in combination with 
other biomarkers to improve diagnosis or accelerate 
drug discovery
15,16
. In this analysis high score for 
MMP-9 was showed by the ligand Pyrrolidine, 1-7-
oxo-2,4,6 trimethylheptanoyl having −6.506 as shown 
in (Fig. 3) and the docking scores were tabulated in 
(Table 3). 
Tumor Necrosis Factor alpha, provocative cytokine 
released by macrophages or monocytes during many 
inflammatory conditions and is liable for prompting 
apoptosis and necrosis. TNFα plays a key role in 
triggering the cytokine cascade in various inflammatory 
diseases. This is considered as a ―master-regulator‖ of 
inflammatory cytokine production and it has been 
suggested as a target for a numerous disorders
17,18
.  
TNF-α crosses BBB by a receptor-mediated 
transportation that is upregulated during ischaemic 
injury
19
. TNF-α activated macrophages are the main 
components involved in number of autoimmune 
diseases. As shown in (Fig. 4 and Table 4) the maximum 
docking score was observed in the compound 
Strychane,1-acetyl-20α- hydroxy-16-methylene with 
−5.054 towards TNF having PDB Id:2AZ5.  
The docking studies show the importance of 
molecular docking approaches in the development and  







Fig. 1 — GC MS chromatogram of (A) hydroalcoholic fraction; (B) ethylacetate fraction; and (C) chloroform fraction of Illicium verum 




Table 1 — The phytocompounds present in Illicium verum fruit obtained from GC MS analysis 
S. No Retention time Compound 
Hydroalcoholic extract 
1 11.38 Hexadecanoic acid, 14 methyl methyl ester 
2 12 Dasycarpidan-1-methanol acetate 
3 12.5 8-11-octadecadienoic acid 
4 13.32 10- Heptadecen-8- enoic acid 
5 14.73 Strychane, 1- acetyl-20α- hydroxyl-16-methylene 
6 16.25 4H-cyclopropa(5,6)benz (1,2:7,8) azuleno (5,6b)) Oxiren-4-one 
Chloroform fraction 
7 9.78 Trans anethole 
8 10.8 2,2,5- Trimethyl-cyclohexane 1,4 diol 
9 12.02 1,E-8,Z-10- Pentadecatriene 
10 12.17 Pyrrolidine, 1-(7-oxo-2,4,6 trimethyl heptanoyl) 
11 13.26 1,5,9,9-Tetramethyl-Spiro (3,5)nonan-5-ol 
12 14.2 Cyclohexanone 2,3,3-trimethyl 2-(3- methylene but-1-en-1-yl) 
13 14.45 4 methyl 5,6 tetramethylene- 3-4- dihydro-1,3-oxazine-2-thione 
14 15.33 1-octene, 2-methoxy 
15 17.61 1-hexen-3-ol,5-nitro-1-phenyl 
16 17.9 Androstan-6-one,3 (acetyloxy)5-hydroxy, (3a,5a) 
17 18.11 Cyclopentadecanone, 2-methyl 
Ethylacetate fraction 
18 10.2 Methyl Z-11- tetradeconate 
19 10.58 1-(2- acetoxyethyl)-3,6- diazahomoad- amantan-9-one oxime 
20 11.27 p-anasaldehyde 
21 12.23 1-Benzazirene-1-carboxylic acid,2,2,5 a 
22 13.38 4-(5-pentyl-3a,4,5,7a-tetrahydro-4 indanyl) butonic acid, methyl ester (stereoisomer 1) 
23 14.87 12-methyl-e,e-2,13-octadcadien-1-ol 
 
Table 2 — Molecular docking analysis of bioactive compounds present in fruits of Illicium verum against Caspase 3  
(PDB Id:1pau)  (Contd.) 












−3.66 1 ARG 341 1.83 −26.746 −41.626 
Dasycarpidan-1-methanol acetate −3.602 1 CYS 285 1.91 −41.967 −51.902 
1,5,9,9-tetramethyl-spirro(3.5)nonan-5-ol −3.572 1 SER 339 2.02 −21.531 −36.256 
2,2,5 –trimethyl-cyclohexane 1,4diol −3.507 1 SER 339 1.66 −19.981 −28.051 
Pyrrolidine, 1-(7-oxo-2,4,6 trimethylheptanoyl −3.37 1 ARG 341 1.73 −31.169 −50.323 
Hexadecanoic acid,14 methyl methyl ester −3.225 1 PHE381B 1.98 −34.351 −62.241 
10-Heptadecen-8-enoic acid −3.102 3 ARG 179 GLN 283 1.89, 2.11 1.81 −26.663 −4.87 
1-hexen-3-ol,5-nitro-1-phenyl- −3.097 1 ARG 341 1.81 −32.301 −36.819 
4 methyl 5,6 tetramethylene- 3-4- dihydro- 
1,3-oxazine-2-thione 
−3.07 1 HIS237 2.02 −25.907 −32.041 
8,11-octadecadienoic acid −3.023 1 PHE381B 2.05 −35.55 −49.288 
P anisaldehyde −2.904 2 ARG 341 CYS 285 2.23, 2.06 −17.759 −18.047 
Trans anethole −2.751 2 ARG 341 2.04, 2.20 −14.298 −22.792 
Methyl Z-11-tetradecenoate −2.413 2 TRP 348 ASN 342 1.81 2.30 −33.455 −58.701 
1-octene, 2-methoxy −2.328 0 - - −19.213 −36.676 
Cyclopentadecanone,2-methyl −1.136 1 CYS 285 2.13 −15.138 −30.888 
1-(2- acetoxyethyl)-3,6- diazahomoad- 
amantan-9-one oxime 
−1.123 1 ARG186 2.06 −18.96 −32.98 
1,E-8,Z-10- Pentadecatriene −1.085 1 GLN 173 1.35 −19.64 −24.87 
(Contd.) 
 




Table 2 — Molecular docking analysis of bioactive compounds present in fruits of Illicium verum against Caspase 3 
(PDB Id:1pau) (Contd.) 










1-Benzazirene-1-carboxylic acid, 2,2,5 a −1.183 0 -- --- −20.21 −33.65 
4-(5-pentyl-3a,4,5,7a-tetrahydro-4 indanyl) 
butonic acid, methyl ester 
−1.09 1 PHE 165 2.18 −19.34 −39.65 
Cyclohexanone 2,3,3-trimethyl 2- 
(3- methylene but-1-en-1-yl) 
−0.98 1 SER 234 1.87 −28.43 −19.32 
4H-cyclopropa(5,6)benz (1,2:7,8) azuleno 
(5,6b)) Oxiren-4-one 
−0.98 0 -- -- −26.43 −16.34 
Androstan-6-one,3 (acetyloxy)5-hydroxy, 
(3a,5a) 
−0.78 1 CYS 256 1.81 −23.65 −29.31 
12-methyl-e,e-2,13-octadcadien-1-ol −0.69 1 GLN 195 1.96 −32.87 −27.43 
 
Table 3 — Molecular docking analysis of bioactive compounds present in fruits of Illicium verum against the enzyme MMP-9  
(PDB Id:2ow1) 












−6.506 1 GLN 402 1.95 −39.63 −55.03 
1-hexen-3-ol,5-nitro-1-phenyl- −5.831 2 GLN 402 PRO 421 1.93 1.96 −48.096 −60.737 
10-Heptadecen-8-enoic acid −5.637 1 ALA 191 1.91 −51.433 −82.638 
Dasycarpidan-1-methanol acetate −5.109 1 HIS 401 2.23 −36.694 −48.582 
8,11- octadecadienoic acid −5.079 2 ARG 424 LEU 418 2.46 2.03 −56.2777 −50.742 
4 methyl 5,6 tetramethylene-3,4-dihydro-
1,3-oxazin-2-thione 
−4.618 0 - - −38.72 −42.239 
P anisaldehyde −4.588 2 ALA 189 LEU 188 2.12 2.11 −30.337 −34.03 
2,2,5 –trimethyl-cyclohexane 1,4diol −4.5 3 ALA 189 LEU 188 HIS 411 2.34 2.09 2.22 −29.886 −42.983 
Hexadecanoic acid,14 methyl methyl ester −4.418 1 ALA 191 1.89 −46.57 −76.64 
Cyclopentadecanone,2-methyl −4.312 1 GLN 402 2.01 −28.683 −36.791 
Trans anethole −4.128 0 - - −32.592 −45.208 
Strychane,1-acetyl-20α- 515ydroxyl-16-
methylene 
−3.943 1 ALA 191 2.36 −31.78 −44.052 
1,5,9,9-tetramethyl-spirro(3.5)nonan-5-ol −3.742 1 ALA 189 1.77 −22.95 −38.3 
Methyl Z-11-tetradecenoate −3.594 1 ALA 191 1.94 −41.412 −60.229 
1-octene,2-methoxy −2.914 1 GLN 402 2.10 −24.368 −50.044 
1-(2- acetoxyethyl)-3,6- diazahomoad- 
amantan-9-one oxime 
−2.834 1 ALA 231 1.23 −23.23 −64.23 
Cyclohexanone2,3,3trimethyl2- 
(3- methylene but-1-en-1-yl) 
−2.49 1 PRO154 1.63 −32.56 −42.45 
12-methyl-e,e-2,13-octadcadien-1-ol −2.45 1 LEU169 1.74 −43.92 −54.21 
1,E-8,Z-10- Pentadecatriene −2.34 1 GLN 219 2.18 −27.76 −34.53 
4-(5-pentyl-3a,4,5,7a tetrahydro-4indanyl) 
butonic acid, methyl ester 
−2.41 0 ALA 212 1.54 −28.50 −35.23 
Androstan-6-one,3 (acetyloxy)5-hydroxy, 
(3a,5a) 
−2.12 1 HIS234 2.13 −39.21 −36.42 
1-Benzazirene-1-carboxylic acid,2,2,5 a −1.87 1 LEU 176 1.76 −25.43 −41.34 
4H-cyclopropa(5,6)benz (1,2:7,8) azuleno 
(5,6b) Oxiren-4-one 
−1.45 1 GLN 136 2.08 −36.73 −45.78 
 






Fig. 2 — 3-Dimensional and 2-Dimensional interaction of Strychane, 1-acetyl-20α- hydroxy-16-methylene against caspase3 (PDB Id:1pau) 
 
Table 4 — Molecular docking analysis of bioactive compounds present in fruits of Illicium verum against the enzyme 
Tumor necrosis factor α (PDB Id:2AZ5) (Contd.) 










Strychane,1-acetyl-20α- hydroxy-16-methylene −5.054 1 TYR 151 2.26 −39.524 −50.13 
1-hexen-3-ol,5-nitro-1-phenyl- −5.046 1 TYR 151 2.10 −29.195 −43.163 
Pyrrolidine, 1-(7-oxo-2,4,6 trimethylheptanoyl −4.733 0 - - −33.814 −54.224 
Hexadecanoic acid,14 methyl methyl ester −4.3 1 TYR 119 2.10 −28.402 −63.469 
2,2,5–trimethyl-cyclohexane 1,4diol −4.27 1 TYR 151 1.87 −25.145 −32.645 
Cyclopentadecanone,2-methyl −4.178 0 - - −31.45 −48.03 
4 methyl 5,6 tetramethylene-3,4-dihydro-1,3-oxazin- 
2-thione 
−4.012 0 - - −29.837 −41.68 
1,5,9,9-tetramethyl-spirro(3.5)nonan-5-ol −3.962 1 LEU 120 1.96 −22.108 −35.274 
Trans anethole −3.674 0 - - −22.782 −31.73 
P anisaldehyde −3.383 0 - - −21.722 −23.697 
Dasycarpidan-1-methanol acetate −4.986 0 - - −15.707 −51.468 
Methyl Z-11-tetradecenoate −2.56 0 - - −28.184 −48.291 
1-octene,2-methoxy −2.456 0 - - −16.931 −42.766 
(Contd.) 




Table 4 — Molecular docking analysis of bioactive compounds present in fruits of Illicium verum against the enzyme 
Tumor necrosis factor α (PDB Id:2AZ5) (Contd.) 










10-Heptadecen-8-enoic acid −4.479 1 TYR 151 1.84 −35.153 −65.942 
8,11-octadecadienoic acid −4.323 1 TYR 151 1.80 −38.498 −63.345 
1-(2- acetoxyethyl)-3,6- diazahomoad- amantan-9-one 
oxime 
−3.92 1 TYR274 1.91 −25.67 −51.50 
1-Benzazirene-1-carboxylic acid,2,2,5 a −3.63 0 - - −13.24 −29.45 
1,E-8,Z-10- Pentadecatriene −3.12 1 LEU 132 2.34 −27.43 −41.34 
4-(5-pentyl-3a,4,5,7a-tetrahydro-4 indanyl) butonic 
acid, methyl ester 
−3.09 1 TYR147 2.16 −21.56 −34.87 
Cyclohexanone 2,3,3-trimethyl 2-(3- methylene but-
1-en-1-yl) 
−2.96 0 - - −19.43 −46.21 
12-methyl-e,e-2,13-octadcadien-1-ol −2.62 1 TYR168 1.98 −19.34 −42.38 
4H-cyclopropa(5,6)benz (1,2:7,8) azule34no (5,6b)) 
Oxiren-4-one 
−1.98 1 ALA213 1.87 −34.78 −51.93 




Fig. 3 — 3-Dimensional and 2-Dimensional interaction of Pyrrolidine, 1-(7-oxo-2,4,6 trimethyl heptanoyl against MMP-9  
(PDB Id:2ow1) 






Fig. 4 — 3-Dimensional and 2-Dimensional interaction of Strychane, 1-acetyl-20α- hydroxy-16 methylene against TNF-  
(PDB Id:2AZ5) 
 
design development of new compounds with biological 
activity. This study provides the significance of 
structure-based drug coming up with strategy towards 
the development of novel medicine while not 
victimization of animals. 
 
Conclusion 
Results revealed that phytoconstituents obtained 
from Illicium verum showed good docking against 
Caspase-3, MMP-9 and TNF- indicating their 
potential against apoptosis and inflammation.  
As apoptosis and inflammation are pathological 
factors for many diseases, screening of these 
compounds in animal models may provide further 
insights into their usefulness to develop novel 
therapeutic agents. 
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